Design and methodology of the ESPRIT trial: Evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

The EPIC Investigators · New England Journal of Medicine · 1994 · 2.6K citations · Full text

Medicine, Cardiology, Hematology +17

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

James H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · Circulation · 1987 · 2.3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery Stents

Albert Schömig, Franz–Josef Neumann, Adnan Kastrati et al. · New England Journal of Medicine · 1996 · 2K citations

Medicine, Cardiology, Pharmacotherapy +17

Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization

The EPILOG Investigators · New England Journal of Medicine · 1997 · 1.9K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal Angioplasty

Ulrich Sigwart, V. Mirkovitch, F. Joffre et al. · New England Journal of Medicine · 1987 · 1.9K citations

Medicine, Cardiology, Surgery +17